Associate (Intellectual Property law) at Bird & Bird LLP. Former member of The Pharmaceutical Journal editorial team (2008-2013).
Roll on the results of this pilot - a cost-effectiveness analysis of this approach will be challenging, but highly worthwhile. Pending any breakthroughs in the drugs pipeline we need to take every effective measure we can to tackle AMR.
Really interesting examples of pharmacists harnessing tech to improve healthcare and services. This sort of needs-driven approach is where the transformative ideas come from.
I'm rather surprised not to see any comments on this story yet. Have you a view on this issue, ye folk of the profession? I'd be intrigued to hear the pharmacy perspective. Or perhaps nobody wants to stick his or her neck out on this one..?